Chronic kidney disease (CKD) is a condition characterized by a gradual loss of renal function over time. To learn more about kidney function, see how your kidneys work. CKD is also known as chronic kidney disease.
Based on the Chronic Kidney Disease (CKD) Drug market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Chronic Kidney Disease (CKD) Drug market covered in Chapter 5:
FibroGen
OPKO Health
Shield Therapeutics
Regulus Therapeutics
Raptor Pharmaceuticals
Akebia Therapeutics
Pharmacosmos
Amgen Inc.
Johnson & Johnson
Cara Therapeutics
Xenetic Biosciences
ZS Pharma
Takeda Pharmaceuticals
Vifor Pharma Ltd
F. Hoffmann-La Roche Ltd
Sanofi
Reata Pharmaceuticals
Rockwell Medical
AMAG Pharmaceuticals
Actavis PLC
Keryx Biopharmaceuticals
Abbott Laboratories
In Chapter 6, on the basis of types, the Chronic Kidney Disease (CKD) Drug market from 2015 to 2025 is primarily split into:
ACE Inhibitors
Angiotensin-II receptor blockers
Calcium channel blockers
Beta blockers
Erythropoiesis-stimulating agents (ESAs)
Diuretics
Others
In Chapter 7, on the basis of applications, the Chronic Kidney Disease (CKD) Drug market from 2015 to 2025 covers:
Hospitals
Specialty Clinics
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Global Chronic Kidney Disease (CKD) Drug Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Chronic Kidney Disease (CKD) Drug Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 FibroGen
5.1.1 FibroGen Company Profile
5.1.2 FibroGen Business Overview
5.1.3 FibroGen Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 FibroGen Chronic Kidney Disease (CKD) Drug Products Introduction
5.2 OPKO Health
5.2.1 OPKO Health Company Profile
5.2.2 OPKO Health Business Overview
5.2.3 OPKO Health Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 OPKO Health Chronic Kidney Disease (CKD) Drug Products Introduction
5.3 Shield Therapeutics
5.3.1 Shield Therapeutics Company Profile
5.3.2 Shield Therapeutics Business Overview
5.3.3 Shield Therapeutics Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Shield Therapeutics Chronic Kidney Disease (CKD) Drug Products Introduction
5.4 Regulus Therapeutics
5.4.1 Regulus Therapeutics Company Profile
5.4.2 Regulus Therapeutics Business Overview
5.4.3 Regulus Therapeutics Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Regulus Therapeutics Chronic Kidney Disease (CKD) Drug Products Introduction
5.5 Raptor Pharmaceuticals
5.5.1 Raptor Pharmaceuticals Company Profile
5.5.2 Raptor Pharmaceuticals Business Overview
5.5.3 Raptor Pharmaceuticals Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Raptor Pharmaceuticals Chronic Kidney Disease (CKD) Drug Products Introduction
5.6 Akebia Therapeutics
5.6.1 Akebia Therapeutics Company Profile
5.6.2 Akebia Therapeutics Business Overview
5.6.3 Akebia Therapeutics Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Akebia Therapeutics Chronic Kidney Disease (CKD) Drug Products Introduction
5.7 Pharmacosmos
5.7.1 Pharmacosmos Company Profile
5.7.2 Pharmacosmos Business Overview
5.7.3 Pharmacosmos Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Pharmacosmos Chronic Kidney Disease (CKD) Drug Products Introduction
5.8 Amgen Inc.
5.8.1 Amgen Inc. Company Profile
5.8.2 Amgen Inc. Business Overview
5.8.3 Amgen Inc. Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Amgen Inc. Chronic Kidney Disease (CKD) Drug Products Introduction
5.9 Johnson & Johnson
5.9.1 Johnson & Johnson Company Profile
5.9.2 Johnson & Johnson Business Overview
5.9.3 Johnson & Johnson Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Johnson & Johnson Chronic Kidney Disease (CKD) Drug Products Introduction
5.10 Cara Therapeutics
5.10.1 Cara Therapeutics Company Profile
5.10.2 Cara Therapeutics Business Overview
5.10.3 Cara Therapeutics Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Cara Therapeutics Chronic Kidney Disease (CKD) Drug Products Introduction
5.11 Xenetic Biosciences
5.11.1 Xenetic Biosciences Company Profile
5.11.2 Xenetic Biosciences Business Overview
5.11.3 Xenetic Biosciences Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Xenetic Biosciences Chronic Kidney Disease (CKD) Drug Products Introduction
5.12 ZS Pharma
5.12.1 ZS Pharma Company Profile
5.12.2 ZS Pharma Business Overview
5.12.3 ZS Pharma Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 ZS Pharma Chronic Kidney Disease (CKD) Drug Products Introduction
5.13 Takeda Pharmaceuticals
5.13.1 Takeda Pharmaceuticals Company Profile
5.13.2 Takeda Pharmaceuticals Business Overview
5.13.3 Takeda Pharmaceuticals Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Takeda Pharmaceuticals Chronic Kidney Disease (CKD) Drug Products Introduction
5.14 Vifor Pharma Ltd
5.14.1 Vifor Pharma Ltd Company Profile
5.14.2 Vifor Pharma Ltd Business Overview
5.14.3 Vifor Pharma Ltd Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Vifor Pharma Ltd Chronic Kidney Disease (CKD) Drug Products Introduction
5.15 F. Hoffmann-La Roche Ltd
5.15.1 F. Hoffmann-La Roche Ltd Company Profile
5.15.2 F. Hoffmann-La Roche Ltd Business Overview
5.15.3 F. Hoffmann-La Roche Ltd Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 F. Hoffmann-La Roche Ltd Chronic Kidney Disease (CKD) Drug Products Introduction
5.16 Sanofi
5.16.1 Sanofi Company Profile
5.16.2 Sanofi Business Overview
5.16.3 Sanofi Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Sanofi Chronic Kidney Disease (CKD) Drug Products Introduction
5.17 Reata Pharmaceuticals
5.17.1 Reata Pharmaceuticals Company Profile
5.17.2 Reata Pharmaceuticals Business Overview
5.17.3 Reata Pharmaceuticals Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Reata Pharmaceuticals Chronic Kidney Disease (CKD) Drug Products Introduction
5.18 Rockwell Medical
5.18.1 Rockwell Medical Company Profile
5.18.2 Rockwell Medical Business Overview
5.18.3 Rockwell Medical Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 Rockwell Medical Chronic Kidney Disease (CKD) Drug Products Introduction
5.19 AMAG Pharmaceuticals
5.19.1 AMAG Pharmaceuticals Company Profile
5.19.2 AMAG Pharmaceuticals Business Overview
5.19.3 AMAG Pharmaceuticals Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 AMAG Pharmaceuticals Chronic Kidney Disease (CKD) Drug Products Introduction
5.20 Actavis PLC
5.20.1 Actavis PLC Company Profile
5.20.2 Actavis PLC Business Overview
5.20.3 Actavis PLC Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.20.4 Actavis PLC Chronic Kidney Disease (CKD) Drug Products Introduction
5.21 Keryx Biopharmaceuticals
5.21.1 Keryx Biopharmaceuticals Company Profile
5.21.2 Keryx Biopharmaceuticals Business Overview
5.21.3 Keryx Biopharmaceuticals Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.21.4 Keryx Biopharmaceuticals Chronic Kidney Disease (CKD) Drug Products Introduction
5.22 Abbott Laboratories
5.22.1 Abbott Laboratories Company Profile
5.22.2 Abbott Laboratories Business Overview
5.22.3 Abbott Laboratories Chronic Kidney Disease (CKD) Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.22.4 Abbott Laboratories Chronic Kidney Disease (CKD) Drug Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Chronic Kidney Disease (CKD) Drug Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Chronic Kidney Disease (CKD) Drug Sales and Market Share by Types (2015-2020)
6.1.2 Global Chronic Kidney Disease (CKD) Drug Revenue and Market Share by Types (2015-2020)
6.1.3 Global Chronic Kidney Disease (CKD) Drug Price by Types (2015-2020)
6.2 Global Chronic Kidney Disease (CKD) Drug Market Forecast by Types (2020-2025)
6.2.1 Global Chronic Kidney Disease (CKD) Drug Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Chronic Kidney Disease (CKD) Drug Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Chronic Kidney Disease (CKD) Drug Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Chronic Kidney Disease (CKD) Drug Sales, Price and Growth Rate of ACE Inhibitors
6.3.2 Global Chronic Kidney Disease (CKD) Drug Sales, Price and Growth Rate of Angiotensin-II receptor blockers
6.3.3 Global Chronic Kidney Disease (CKD) Drug Sales, Price and Growth Rate of Calcium channel blockers
6.3.4 Global Chronic Kidney Disease (CKD) Drug Sales, Price and Growth Rate of Beta blockers
6.3.5 Global Chronic Kidney Disease (CKD) Drug Sales, Price and Growth Rate of Erythropoiesis-stimulating agents (ESAs)
6.3.6 Global Chronic Kidney Disease (CKD) Drug Sales, Price and Growth Rate of Diuretics
6.3.7 Global Chronic Kidney Disease (CKD) Drug Sales, Price and Growth Rate of Others
6.4 Global Chronic Kidney Disease (CKD) Drug Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 ACE Inhibitors Market Revenue and Sales Forecast (2020-2025)
6.4.2 Angiotensin-II receptor blockers Market Revenue and Sales Forecast (2020-2025)
6.4.3 Calcium channel blockers Market Revenue and Sales Forecast (2020-2025)
6.4.4 Beta blockers Market Revenue and Sales Forecast (2020-2025)
6.4.5 Erythropoiesis-stimulating agents (ESAs) Market Revenue and Sales Forecast (2020-2025)
6.4.6 Diuretics Market Revenue and Sales Forecast (2020-2025)
6.4.7 Others Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Chronic Kidney Disease (CKD) Drug Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Chronic Kidney Disease (CKD) Drug Sales and Market Share by Applications (2015-2020)
7.1.2 Global Chronic Kidney Disease (CKD) Drug Revenue and Market Share by Applications (2015-2020)
7.2 Global Chronic Kidney Disease (CKD) Drug Market Forecast by Applications (2020-2025)
7.2.1 Global Chronic Kidney Disease (CKD) Drug Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Chronic Kidney Disease (CKD) Drug Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Chronic Kidney Disease (CKD) Drug Revenue, Sales and Growth Rate of Hospitals (2015-2020)
7.3.2 Global Chronic Kidney Disease (CKD) Drug Revenue, Sales and Growth Rate of Specialty Clinics (2015-2020)
7.4 Global Chronic Kidney Disease (CKD) Drug Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Hospitals Market Revenue and Sales Forecast (2020-2025)
7.4.2 Specialty Clinics Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Chronic Kidney Disease (CKD) Drug Sales by Regions (2015-2020)
8.2 Global Chronic Kidney Disease (CKD) Drug Market Revenue by Regions (2015-2020)
8.3 Global Chronic Kidney Disease (CKD) Drug Market Forecast by Regions (2020-2025)
9 North America Chronic Kidney Disease (CKD) Drug Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
9.3 North America Chronic Kidney Disease (CKD) Drug Market Revenue and Growth Rate (2015-2020)
9.4 North America Chronic Kidney Disease (CKD) Drug Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Chronic Kidney Disease (CKD) Drug Market Analysis by Country
9.6.1 U.S. Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
9.6.2 Canada Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
9.6.3 Mexico Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
10 Europe Chronic Kidney Disease (CKD) Drug Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
10.3 Europe Chronic Kidney Disease (CKD) Drug Market Revenue and Growth Rate (2015-2020)
10.4 Europe Chronic Kidney Disease (CKD) Drug Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Chronic Kidney Disease (CKD) Drug Market Analysis by Country
10.6.1 Germany Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
10.6.2 United Kingdom Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
10.6.3 France Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
10.6.4 Italy Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
10.6.5 Spain Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
10.6.6 Russia Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
11 Asia-Pacific Chronic Kidney Disease (CKD) Drug Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Chronic Kidney Disease (CKD) Drug Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Chronic Kidney Disease (CKD) Drug Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Chronic Kidney Disease (CKD) Drug Market Analysis by Country
11.6.1 China Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
11.6.2 Japan Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
11.6.3 South Korea Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
11.6.4 Australia Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
11.6.5 India Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
12 South America Chronic Kidney Disease (CKD) Drug Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
12.3 South America Chronic Kidney Disease (CKD) Drug Market Revenue and Growth Rate (2015-2020)
12.4 South America Chronic Kidney Disease (CKD) Drug Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Chronic Kidney Disease (CKD) Drug Market Analysis by Country
12.6.1 Brazil Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
12.6.2 Argentina Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
12.6.3 Columbia Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
13 Middle East and Africa Chronic Kidney Disease (CKD) Drug Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Chronic Kidney Disease (CKD) Drug Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Chronic Kidney Disease (CKD) Drug Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Chronic Kidney Disease (CKD) Drug Market Analysis by Country
13.6.1 UAE Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
13.6.2 Egypt Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
13.6.3 South Africa Chronic Kidney Disease (CKD) Drug Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate 2015-2025
Table Chronic Kidney Disease (CKD) Drug Key Market Segments
Figure Global Chronic Kidney Disease (CKD) Drug Market Revenue ($) Segment by Type from 2015-2020
Figure Global Chronic Kidney Disease (CKD) Drug Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Chronic Kidney Disease (CKD) Drug
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table FibroGen Company Profile
Table FibroGen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure FibroGen Production and Growth Rate
Figure FibroGen Market Revenue ($) Market Share 2015-2020
Table OPKO Health Company Profile
Table OPKO Health Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure OPKO Health Production and Growth Rate
Figure OPKO Health Market Revenue ($) Market Share 2015-2020
Table Shield Therapeutics Company Profile
Table Shield Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Shield Therapeutics Production and Growth Rate
Figure Shield Therapeutics Market Revenue ($) Market Share 2015-2020
Table Regulus Therapeutics Company Profile
Table Regulus Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Regulus Therapeutics Production and Growth Rate
Figure Regulus Therapeutics Market Revenue ($) Market Share 2015-2020
Table Raptor Pharmaceuticals Company Profile
Table Raptor Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Raptor Pharmaceuticals Production and Growth Rate
Figure Raptor Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Akebia Therapeutics Company Profile
Table Akebia Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Akebia Therapeutics Production and Growth Rate
Figure Akebia Therapeutics Market Revenue ($) Market Share 2015-2020
Table Pharmacosmos Company Profile
Table Pharmacosmos Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pharmacosmos Production and Growth Rate
Figure Pharmacosmos Market Revenue ($) Market Share 2015-2020
Table Amgen Inc. Company Profile
Table Amgen Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Amgen Inc. Production and Growth Rate
Figure Amgen Inc. Market Revenue ($) Market Share 2015-2020
Table Johnson & Johnson Company Profile
Table Johnson & Johnson Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Market Revenue ($) Market Share 2015-2020
Table Cara Therapeutics Company Profile
Table Cara Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Cara Therapeutics Production and Growth Rate
Figure Cara Therapeutics Market Revenue ($) Market Share 2015-2020
Table Xenetic Biosciences Company Profile
Table Xenetic Biosciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Xenetic Biosciences Production and Growth Rate
Figure Xenetic Biosciences Market Revenue ($) Market Share 2015-2020
Table ZS Pharma Company Profile
Table ZS Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure ZS Pharma Production and Growth Rate
Figure ZS Pharma Market Revenue ($) Market Share 2015-2020
Table Takeda Pharmaceuticals Company Profile
Table Takeda Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Takeda Pharmaceuticals Production and Growth Rate
Figure Takeda Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Vifor Pharma Ltd Company Profile
Table Vifor Pharma Ltd Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Vifor Pharma Ltd Production and Growth Rate
Figure Vifor Pharma Ltd Market Revenue ($) Market Share 2015-2020
Table F. Hoffmann-La Roche Ltd Company Profile
Table F. Hoffmann-La Roche Ltd Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure F. Hoffmann-La Roche Ltd Production and Growth Rate
Figure F. Hoffmann-La Roche Ltd Market Revenue ($) Market Share 2015-2020
Table Sanofi Company Profile
Table Sanofi Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sanofi Production and Growth Rate
Figure Sanofi Market Revenue ($) Market Share 2015-2020
Table Reata Pharmaceuticals Company Profile
Table Reata Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Reata Pharmaceuticals Production and Growth Rate
Figure Reata Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Rockwell Medical Company Profile
Table Rockwell Medical Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Rockwell Medical Production and Growth Rate
Figure Rockwell Medical Market Revenue ($) Market Share 2015-2020
Table AMAG Pharmaceuticals Company Profile
Table AMAG Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure AMAG Pharmaceuticals Production and Growth Rate
Figure AMAG Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Actavis PLC Company Profile
Table Actavis PLC Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Actavis PLC Production and Growth Rate
Figure Actavis PLC Market Revenue ($) Market Share 2015-2020
Table Keryx Biopharmaceuticals Company Profile
Table Keryx Biopharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Keryx Biopharmaceuticals Production and Growth Rate
Figure Keryx Biopharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Abbott Laboratories Company Profile
Table Abbott Laboratories Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Abbott Laboratories Production and Growth Rate
Figure Abbott Laboratories Market Revenue ($) Market Share 2015-2020
Table Global Chronic Kidney Disease (CKD) Drug Sales by Types (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Sales Share by Types (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Revenue ($) by Types (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Revenue Share by Types (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Price ($) by Types (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Market Forecast Sales by Types (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drug Market Forecast Sales Share by Types (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drug Market Forecast Revenue ($) by Types (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drug Market Forecast Revenue Share by Types (2020-2025)
Figure Global ACE Inhibitors Sales and Growth Rate (2015-2020)
Figure Global ACE Inhibitors Price (2015-2020)
Figure Global Angiotensin-II receptor blockers Sales and Growth Rate (2015-2020)
Figure Global Angiotensin-II receptor blockers Price (2015-2020)
Figure Global Calcium channel blockers Sales and Growth Rate (2015-2020)
Figure Global Calcium channel blockers Price (2015-2020)
Figure Global Beta blockers Sales and Growth Rate (2015-2020)
Figure Global Beta blockers Price (2015-2020)
Figure Global Erythropoiesis-stimulating agents (ESAs) Sales and Growth Rate (2015-2020)
Figure Global Erythropoiesis-stimulating agents (ESAs) Price (2015-2020)
Figure Global Diuretics Sales and Growth Rate (2015-2020)
Figure Global Diuretics Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Market Revenue ($) and Growth Rate Forecast of ACE Inhibitors (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Sales and Growth Rate Forecast of ACE Inhibitors (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Revenue ($) and Growth Rate Forecast of Angiotensin-II receptor blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Sales and Growth Rate Forecast of Angiotensin-II receptor blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Revenue ($) and Growth Rate Forecast of Calcium channel blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Sales and Growth Rate Forecast of Calcium channel blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Revenue ($) and Growth Rate Forecast of Beta blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Sales and Growth Rate Forecast of Beta blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Revenue ($) and Growth Rate Forecast of Erythropoiesis-stimulating agents (ESAs) (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Sales and Growth Rate Forecast of Erythropoiesis-stimulating agents (ESAs) (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Revenue ($) and Growth Rate Forecast of Diuretics (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Sales and Growth Rate Forecast of Diuretics (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Sales and Growth Rate Forecast of Others (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drug Sales by Applications (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Sales Share by Applications (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Revenue ($) by Applications (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Revenue Share by Applications (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Market Forecast Sales by Applications (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drug Market Forecast Sales Share by Applications (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drug Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drug Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Hospitals Sales and Growth Rate (2015-2020)
Figure Global Hospitals Price (2015-2020)
Figure Global Specialty Clinics Sales and Growth Rate (2015-2020)
Figure Global Specialty Clinics Price (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Market Revenue ($) and Growth Rate Forecast of Hospitals (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Sales and Growth Rate Forecast of Hospitals (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Revenue ($) and Growth Rate Forecast of Specialty Clinics (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Sales and Growth Rate Forecast of Specialty Clinics (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Sales by Regions (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Sales Market Share by Regions (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Sales Market Share by Regions in 2019
Figure Global Chronic Kidney Disease (CKD) Drug Revenue and Growth Rate (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Revenue by Regions (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Revenue Market Share by Regions (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Revenue Market Share by Regions in 2019
Table Global Chronic Kidney Disease (CKD) Drug Market Forecast Sales by Regions (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drug Market Forecast Sales Share by Regions (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drug Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Chronic Kidney Disease (CKD) Drug Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure North America Chronic Kidney Disease (CKD) Drug Market Revenue and Growth Rate (2015-2020)
Figure North America Chronic Kidney Disease (CKD) Drug Market Forecast Sales (2020-2025)
Figure North America Chronic Kidney Disease (CKD) Drug Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Canada Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Mexico Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Europe Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Europe Chronic Kidney Disease (CKD) Drug Market Revenue and Growth Rate (2015-2020)
Figure Europe Chronic Kidney Disease (CKD) Drug Market Forecast Sales (2020-2025)
Figure Europe Chronic Kidney Disease (CKD) Drug Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure France Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Italy Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Spain Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Russia Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Chronic Kidney Disease (CKD) Drug Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Chronic Kidney Disease (CKD) Drug Market Forecast Sales (2020-2025)
Figure Asia-Pacific Chronic Kidney Disease (CKD) Drug Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Japan Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure South Korea Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Australia Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure India Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure South America Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure South America Chronic Kidney Disease (CKD) Drug Market Revenue and Growth Rate (2015-2020)
Figure South America Chronic Kidney Disease (CKD) Drug Market Forecast Sales (2020-2025)
Figure South America Chronic Kidney Disease (CKD) Drug Market Forecast Revenue ($) (2020-2025)
Figure Brazil Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Argentina Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Columbia Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Drug Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Drug Market Forecast Sales (2020-2025)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Drug Market Forecast Revenue ($) (2020-2025)
Figure UAE Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure Egypt Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Figure South Africa Chronic Kidney Disease (CKD) Drug Market Sales and Growth Rate (2015-2020)
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
